Artivion (AORT) Cash from Investing Activities (2010 - 2026)

Artivion (AORT) posted Cash from Investing Activities of -$10.5 million for Q1 2026, up 65.57% on a QoQ basis from -$30.5 million in Q4 2025, and down 188.7% year-over-year from $11.8 million in Q1 2025.

Artivion (AORT) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Artivion's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$10.5 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 188.7% year-over-year to -$10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.9 million (down 73.33% YoY) and the FY2025 annual result came in at -$42.0 million, down 49.15% from the prior year.
  • Cash from Investing Activities was -$10.5 million for Q1 2026 at Artivion, up from -$30.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.1 million in Q2 2023 and bottomed at -$30.5 million in Q4 2025.
  • A 5-year average of -$5.4 million and a median of -$3.1 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 409.62% — and 2024, when it plunged 414.46%.
  • Artivion's Cash from Investing Activities stood at -$2.7 million in 2022, then slipped by 0.04% to -$2.7 million in 2023, then tumbled by 328.06% to -$11.4 million in 2024, then slumped by 167.02% to -$30.5 million in 2025, then surged by 65.57% to -$10.5 million in 2026.
  • Business Quant data shows AORT's Cash from Investing Activities at -$10.5 million in Q1 2026, -$30.5 million in Q4 2025, and -$4.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -20.32 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -185.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -92.80 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -298.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -475.32 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -2.50 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Artivion 1.25 Bn 1.19 Bn 75.45 Mn -10.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.50 Mn
Mar 31, 2026 -10.50 Mn
Dec 31, 2025 -30.51 Mn
Dec 31, 2025 -30.51 Mn
Sep 30, 2025 -4.61 Mn
Sep 30, 2025 -4.61 Mn
Jun 30, 2025 -3.29 Mn
Jun 30, 2025 -3.29 Mn
Mar 31, 2025 -3.64 Mn
Mar 31, 2025 -3.64 Mn
Dec 31, 2024 -11.43 Mn
Dec 31, 2024 -11.43 Mn
Sep 30, 2024 -10.64 Mn
Sep 30, 2024 -10.64 Mn
Jun 30, 2024 -2.51 Mn
Jun 30, 2024 -2.51 Mn
Mar 31, 2024 -3.61 Mn
Mar 31, 2024 -3.61 Mn
Dec 31, 2023 -2.67 Mn
Dec 31, 2023 -2.67 Mn